Studies have shown that patients with BRCA1 and BRCA2 mutations are susceptible to developing BC associated with OC, and the probability of developing epithelial-type BC is higher, as is that of developing the histological subtype of serous OC (38, 42–44). The gene discussed is BRCA1; the disease is breast cancer.